The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.
The European Medicines Agency’s (EMA) on Friday released a set of recommendations for health care professionals to follow to avoid dosing errors with methotrexate-containing medicines. The ...
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
Verywell Health on MSN
Does methotrexate cause weight gain?
Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways Methotrexate may cause modest weight gain, especially if you are underweight when you start treatment.If you gain weight on methotrexate ...
Alembic Pharmaceuticals' shares rose after receiving USFDA approval for its generic cancer treatment drug, Methotrexate ...
Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...
Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results